Person Prof David Ashley National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Participant in A 2:1 Randomised Phase II Study of NivolUmab and Temozolomide vs Temozolomide in Methylated newly diagnosed Elderly Glioblastoma (NUTMEG) (funded by National Health and Medical Research Council) Participant in, Principal investigator of A Phase II Study of continuous, low-dose LBH 589 (Panobinostat) in Patients with Refractory Solid Tumors, including CNS tumors (funded by National Health and Medical Research Council) Participant in M-Health: Efficacy and Cost-effectiveness of a smartphone App to reduce unmet needs and distress in people with cancer (ACE): a randomized controlled trial (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Participant in A 2:1 Randomised Phase II Study of NivolUmab and Temozolomide vs Temozolomide in Methylated newly diagnosed Elderly Glioblastoma (NUTMEG) (funded by National Health and Medical Research Council) Participant in, Principal investigator of A Phase II Study of continuous, low-dose LBH 589 (Panobinostat) in Patients with Refractory Solid Tumors, including CNS tumors (funded by National Health and Medical Research Council) Participant in M-Health: Efficacy and Cost-effectiveness of a smartphone App to reduce unmet needs and distress in people with cancer (ACE): a randomized controlled trial (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
